Brief: Provectus Biopharmaceuticals terminates Peter Culpepper as interim CEO and COO
28/12/2016 22:15
Dec 28 (Reuters) - Provectus Biopharmaceuticals Inc
PVCT.PK
* Provectus Biopharmaceuticals terminates Peter Culpepper as
interim CEO and COO
Source text for Eikon: ID:nBw3kWqBqa
Further company coverage: PVCT.PK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Provectus Biopharmaceuticals
See all newsBrief: Provectus Biopharmaceuticals Reports Oral Pv-10 Anti-Tumor Activity In Preclinical Bladder Cancer Study
Brief: Provectus Biopharmaceuticals Initiates Preclinical Study Of Oral Pv-10
RCS - VisiRose - VisiRose Introduces Therapy for Eye Infections
RCS - FINOS - FINOS Welcomes Seven Financial Leaders
Brief: Provectus Biopharmaceuticals Announces Poster Presentation of Rose Bengal Sodium for Treatment of Full-Thickness Cutaneous Wounds at SID 2024 Annual Meeting